Chinook Therapeutics Inc
NASDAQ:KDNY

Watchlist Manager
Chinook Therapeutics Inc Logo
Chinook Therapeutics Inc
NASDAQ:KDNY
Watchlist
Price: 40.39 USD Market Closed
Updated: May 19, 2024

Chinook Therapeutics Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chinook Therapeutics Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Chinook Therapeutics Inc
NASDAQ:KDNY
Interest Income Expense
-$594k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
11%
CAGR 5-Years
-6%
CAGR 10-Years
-18%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$663m
CAGR 3-Years
38%
CAGR 5-Years
3%
CAGR 10-Years
-8%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.9B
CAGR 3-Years
-44%
CAGR 5-Years
-30%
CAGR 10-Years
-16%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$630.1m
CAGR 3-Years
93%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$221.8m
CAGR 3-Years
-13%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is Chinook Therapeutics Inc's Interest Income Expense?
Interest Income Expense
-594k USD

Based on the financial report for Jun 30, 2023, Chinook Therapeutics Inc's Interest Income Expense amounts to -594k USD.

What is Chinook Therapeutics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
86%

Over the last year, the Interest Income Expense growth was 86%.